Telmisartan and Rosuvastatin Tablets 40/10 mg

Adult dose

Telmisartan: For the treatment of essential hypertension, an oral dose of 40 mg once daily is recommended, which may be effective at 20 mg once daily depending on the patient. If necessary, the dose may be increased to 80 mg once daily. For the purpose of reducing the risk of cardiovascular disease, an oral dose of 80 mg once daily is recommended. Patients with hepatic impairment (mild to moderate) should not exceed 40 mg once daily. Rosuvastatin Calcium: Primarily for

This medication should not be taken during pregnancy. Taking this medication during pregnancy can cause serious harm to the fetus, and in severe cases, may lead to fetal death. If pregnancy is confirmed, discontinue use immediately. This medication should not be administered to individuals allergic to its components, pregnant women or those who may become pregnant, or breastfeeding women. Particularly, women of childbearing potential should only take this medication if they are aware of the potential risks to the fetus. It is safe to avoid use in patients with severe liver impairment, problems with bile excretion, active liver disease, muscle disorders, history of vascular swelling, severe renal dysfunction, or when combined with specific immunosuppressants. Elderly patients, those with high serum potassium levels, mild liver dysfunction, cardiovascular or vascular disorders, gastrointestinal disorders, or renal vascular disorders should use this medication cautiously, and regular blood tests and liver function tests should be conducted during treatment. This medication may cause muscle-related adverse effects such as myalgia, muscle weakness, or cramps; consult a physician immediately if these symptoms occur, particularly to assess muscle damage through creatine kinase (CK) testing. Adverse effects such as liver function abnormalities, hypotension, dizziness, dyspepsia, and pruritus may occur, so report any unusual symptoms to healthcare professionals. When taking this medication with others, be mindful of interactions, particularly when combined with antihypertensives, certain lipid-lowering agents, diuretics, and potassium supplements; blood pressure, renal function, and electrolyte levels should be monitored frequently. Pregnant or breastfeeding women should not take this medication, and women planning to become pregnant should use appropriate contraception. Safety and efficacy in pediatric populations have not been established, so avoiding administration in children is advisable. In cases of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur; seek appropriate treatment immediately at a medical facility. Lastly, keep this medication out of the reach of children, and avoid transferring it to other containers.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthmatic attack, respiratory distress accompanied by cough and fever, skin or eye yellowing (jaundice), profound lethargy, sudden and severe headache, thunderclap headache, seizure, confusion, vision disturbances, paralysis, urination

Mild side effects

• Dyspepsia
• oral paresthesia
• muscular stiffness
• acne
• pruritus
• dizziness
• nasopharyngitis
• dysuria
• rhinitis
• oral discomfort

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius. This will help preserve the medication's efficacy.

Appearance

Light orange oval film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP x 3]